The neurovascular interventions market, a sought-after segment in the medical sector, is replete with rapid technological advancements aimed at more effective brain aneurysm treatments. Interdisciplinary collaboration has led to significantly improved patient outcomes and reduced complications. Techniques like endovascular coiling and flow diverters are growing in popularity due to their...
Discover more insightsThe global market for intracranial aneurysm and stents is primarily determined by the rising prevalence of brain aneurysm cases, and the subsequent need for effective treatment strategies. Technological advancements in stent design and functionality have allowed for greater efficiency in aneurysm intervention, driving demand within the sector. On a geographically...
Discover more insightsGlioblastoma Multiforme (GBM) is an aggressive type of brain cancer with limited treatment options. The standard of care includes surgery, radiation and chemotherapy, which, while offering limited improvement, are generally associated with significant side-effects and a low survival rate; the median survival sits at approximately 15 months. Developing more effective...
Discover more insightsPresent therapies for brain tumors fall between two problematic poles: lack of specificity and debilitating side effects. Despite advances in technology and pharmacology, the deliverance of treatment to the brain is physiologically confronted by the blood-brain barrier which limits the efficacy of many drugs. Meanwhile, systemic chemotherapy, though largely effective,...
Discover more insightsThere is an increased array of promising drugs in the pipeline for Gliosarcoma, a rare and aggressive type of brain cancer. Scientific advancements have led to a streamlined research process focused on reducing the severity and enhancing the effectiveness of treatments, with biologic therapies, targeted treatments and immunotherapies being closely...
Discover more insightsNotably, neuroblastoma, a cancer primarily affecting infants and young children, presents unique challenges in drug development. The complexity of this tumor necessitates innovative and targeted therapies. As it stands, pharmaceutical research continually seeks to identify and evaluate potential efficacious compounds, expanding the global neuroblastoma drugs pipeline. Nevertheless, despite these concerted...
Discover more insightsDevelopments in medical technology have greatly advanced the ways Retinoblastoma, an eye cancer affecting children, is treated. The introduction of treatments such as systemic chemotherapy, intra-arterial and intravitreal chemotherapy have resulted in substantial improvements over the traditional cryotherapy, thermotherapy, or radiotherapy-based practices. Improved diagnosis, precise localization of tumors, and enhanced...
Discover more insightsStudying the market dynamics of brain tumor diagnosis and treatment, it's noticeable that the segment exhibits significant potential, especially in the domain of Glioma and Glioblastoma Multiforme. The drivers of this growth include advancements in neuroimaging techniques, rise in health care expenditure, and an increasing global geriatric population prone to...
Discover more insights